| Cas No.: | 1000998-62-8 | 
| Chemical Name: | N-[[5-[[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]methoxy]-2-fluorophenyl]methyl]-N-(methoxycarbonyl)-glycine | 
| Synonyms: | BMS 711939;BMS711939 | 
| Formula: | C22H20ClFN2O6 | 
| M.Wt: | 462.858 | 
| Purity: | >98% | 
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO | 
| Description: | A potent and selective human PPARα agonist with EC50 of 4 nM, >1,000-fold selectivity over human PPARγ (EC50=4.5 uM) and PPARδ (EC50 >100 uM) in PPAR-GAL4 transactivation assays; shows much lower potency against mouse PPARα than human PPARα, robustly increases apolipoprotein (Apo) A1 and high-density lipoprotein cholesterol in human ApoA1 transgenic mice and lower low-density lipoprotein-cholesterol and triglycerides in fat-fed hamsters, also prevents the LXR agonist-induced elevation of serum triglycerides. | 

 To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
            
 
                 
                             
                             
                             
                             
                             
                             
                             
                             
                             
                             
                             
                             
                             
                             
                             
                             
                             
                            